Top news
Oxford vaccine trial on hold because of potential safety issue
By Erika Edwards & Sara G. Miller
Putting our money on two COVID vaccines is better than one: why Australia's latest vaccine deal makes sense
By Kylie M. Quinn
AstraZeneca CEO says participant had neurological symptoms, could be discharged today
By Adam Feuerstein
All coverage
AstraZeneca shares drop after company announces 'routine' safety pause in coronavirus vaccine trial
By Berkeley Lovelace & Berkeley Lovelace Jr.
Inside Oxford's Vaccine Saga: From Wild Hype to Sobering Reality
By Elizabeth Ralph
Oxford Vaccine: AstraZeneca Pauses Trial After Unexplained Illness
By Michelle Cortez & Riley Griffin
Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant
By Elias Visontay
Safety Review Begins Into AstraZeneca's Coronavirus Vaccine Trial
By Katherine J. Wu
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
By Rebecca Robbins, Helen Branswell & Adam Feuerstein
AstraZeneca Pauses Vaccine Trial for Safety Review
By Katherine J. Wu & Katie Thomas